Based on early cellular studies (Isakoff et al, 2005; Kang et al, 2005; Samuels et al, 2005), common cancer-associated PIK3CA mutations such as PIK3CAH1047R are often regarded simply as “on” switches, or activators, of the pathway. Here, PIK3CA is linked to cancer.